![]() |
Name |
2-Heptylfuran
|
Molecular Formula | C11H18O | |
IUPAC Name* |
2-heptylfuran
|
|
SMILES |
CCCCCCCC1=CC=CO1
|
|
InChI |
InChI=1S/C11H18O/c1-2-3-4-5-6-8-11-9-7-10-12-11/h7,9-10H,2-6,8H2,1H3
|
|
InChIKey |
BHTUFJXTYNLISA-UHFFFAOYSA-N
|
|
Synonyms |
2-HEPTYLFURAN; 2-n-Heptylfuran; 3777-71-7; Furan, 2-heptyl-; FEMA No. 3401; 7W55A39QXM; Furan, heptyl-; CCRIS 6901; UNII-7W55A39QXM; 2-heptyluran; 2-heptyl furan; EINECS 223-236-8; HEPTYLFURAN, 2-N-; 2-HEPTYLFURAN [FHFI]; SCHEMBL1868812; DTXSID2063187; FEMA 3401; CHEBI:167091; MFCD00051820; ZINC95619429; AKOS005266535; PS-11660; DB-021419; FT-0612487; A823864; Q27268935
|
|
CAS | 3777-71-7 | |
PubChem CID | 19603 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 166.26 | ALogp: | 4.7 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 13.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 12 | QED Weighted: | 0.568 |
Caco-2 Permeability: | -4.346 | MDCK Permeability: | 0.00001590 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.018 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.653 |
30% Bioavailability (F30%): | 0.965 |
Blood-Brain-Barrier Penetration (BBB): | 0.433 | Plasma Protein Binding (PPB): | 96.96% |
Volume Distribution (VD): | 2.53 | Fu: | 2.44% |
CYP1A2-inhibitor: | 0.979 | CYP1A2-substrate: | 0.662 |
CYP2C19-inhibitor: | 0.839 | CYP2C19-substrate: | 0.123 |
CYP2C9-inhibitor: | 0.719 | CYP2C9-substrate: | 0.801 |
CYP2D6-inhibitor: | 0.057 | CYP2D6-substrate: | 0.211 |
CYP3A4-inhibitor: | 0.098 | CYP3A4-substrate: | 0.213 |
Clearance (CL): | 7.91 | Half-life (T1/2): | 0.42 |
hERG Blockers: | 0.131 | Human Hepatotoxicity (H-HT): | 0.066 |
Drug-inuced Liver Injury (DILI): | 0.231 | AMES Toxicity: | 0.026 |
Rat Oral Acute Toxicity: | 0.395 | Maximum Recommended Daily Dose: | 0.034 |
Skin Sensitization: | 0.639 | Carcinogencity: | 0.361 |
Eye Corrosion: | 0.973 | Eye Irritation: | 0.993 |
Respiratory Toxicity: | 0.907 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000533 | ![]() |
0.829 | D07UHS | ![]() |
0.329 | ||
ENC000546 | ![]() |
0.694 | D05ATI | ![]() |
0.262 | ||
ENC000617 | ![]() |
0.500 | D02MLW | ![]() |
0.259 | ||
ENC000049 | ![]() |
0.395 | D0E7PQ | ![]() |
0.254 | ||
ENC000261 | ![]() |
0.395 | D03ZJE | ![]() |
0.253 | ||
ENC000897 | ![]() |
0.395 | D0OR6A | ![]() |
0.247 | ||
ENC000032 | ![]() |
0.395 | D0G2KD | ![]() |
0.244 | ||
ENC001477 | ![]() |
0.391 | D0AY9Q | ![]() |
0.242 | ||
ENC000454 | ![]() |
0.378 | D01QLH | ![]() |
0.239 | ||
ENC000687 | ![]() |
0.378 | D0Z5SM | ![]() |
0.236 |